Synbio Technologies

About:

Synbio Technologies offers molecular biology services, recombinant protein expression services, and antibody engineering services.

Website: http://www.synbio-tech.com.cn

Twitter/X: synbio_tech

Top Investors: Cowin Venture, ShareLink Capital, Tianjin Yahui Mingze Asset Management, Huada Yixue

Description:

Synbio Technologies provides hybridoma antibody gene sequencing, immune repertoire sequencing, antibody design, antibody humanization, monoclonal antibody preparation, polyclonal antibody preparation, preparation of recombinant engineering antibodies, stable cell line construction, plasmid preparation, and point mutation.

Total Funding Amount:

120M CNY

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Suzhou Shi, Jiangsu, China

Founded Date:

2013-08-07

Contact Email:

support(AT)synbio-tech.com

Founders:

Ping Yang

Number of Employees:

101-250

Last Funding Date:

2018-07-24

IPO Status:

Public

Industries:

© 2025 bioDAO.ai